Researchers investigating the use of blue scorpion venom as a cancer treatment have identified certain chemicals, called peptides, contained in the venom that can help destroy cancer cells and avoid the side effects of chemotherapy and other conventional cancer treatments. The peptide, chlorotoxin, is the same chemical that paralyzes a scorpion’s prey. In one study, published in 2015 by Science Daily, researchers found that these peptides bind specifically to cancer cells and shrink and destroy them.
An 8-year clinical study conducted by one of the companies that markets a blue scorpion venom cancer drug reported a 90% success rate for more than 8,000 patients with various forms and severity of the disease.